David E. Lazar - Apr 5, 2024 Form 4/A Insider Report for OPGEN INC (OPGN)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David E. Lazar
Stock symbol
OPGN
Transactions as of
Apr 5, 2024
Transactions value $
$200,000
Form type
4/A
Date filed
7/31/2024, 07:05 PM
Date Of Original Report
Apr 8, 2024
Previous filing
Apr 3, 2024
Next filing
Apr 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPGN Series E Convertible Preferred Stock Award $200K +200K $1.00 200K Apr 5, 2024 Common Stock 480K Direct F1, F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2024, David E. Lazar (the "Reporting Person") and OpGen, Inc. (the "Company"), entered into a securies purchase agreement pursuant to which the Reporting Person will acquire an aggregate of 3,000,000 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a price of $1.00 per share. Each share of Series E Preferred Stock is convertible into 24 shares of the Company's Common Stock at any time, subject to certain ownership limitations. The initial closing took place on March 25, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. An additional closing occurred on April 5, 2024, whereby the Reporting Person acquired 200,000 shares of Series E Preferred Stock for a total purchase price of $200,000. The Reporting Person will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.
F2 The shares of Series E Preferred Stock are convertible at the option of the Reporting Person for no additional consideration.
F3 This Form 4/A is being filed solely to change the transaction code previously provided to identify the transaction reported as exempt from Section 16(b) pursuant to Rule 16b-3.
F4 The Series E Preferred Stock is perpetual and therefore has no expiration date.
F5 The reported number of shares of Common Stock underlying the shares of Series E Preferred Stock has been adjusted to reflect a reverse stock split of the Company's Common Stock effective as of May 20, 2024.